Last update 16 May 2025

WBMP-4

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
WBMP-4
Target
mIgM
Action
inhibitors
Mechanism
mIgM inhibitors(membrane IgM inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesInfectious Diseases+ [2]
Active Indication
B-Cell Malignant NeoplasmB-Cell LeukemiaBurkitt Lymphoma
Inactive Indication-
Originator Organization
Welt Bio-Molecular Pharmaceutical
Active Organization
Akron Rubber Development Laboratory, Inc.Akron Rubber Development Laboratory, Inc.Welt Bio-Molecular PharmaceuticalBiogent Consultants, LLC
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with WBMP-4
Login to view more data
100 Translational Medicine associated with WBMP-4
Login to view more data
100 Patents (Medical) associated with WBMP-4
Login to view more data
100 Deals associated with WBMP-4
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
B-Cell Malignant NeoplasmPreclinical
United States
Welt Bio-Molecular Pharmaceutical
28 Apr 2025
B-Cell Malignant NeoplasmPreclinical
United States
Biogent Consultants, LLC
28 Apr 2025
B-Cell LeukemiaPreclinical
United States
Akron Rubber Development Laboratory, Inc.Akron Rubber Development Laboratory, Inc.
22 Mar 2024
B-Cell LeukemiaPreclinical
United States
Biogent Consultants, LLC
22 Mar 2024
B-Cell LeukemiaPreclinical
United States
Welt Bio-Molecular Pharmaceutical
22 Mar 2024
Burkitt LymphomaPreclinical
United States
Akron Rubber Development Laboratory, Inc.Akron Rubber Development Laboratory, Inc.
22 Mar 2024
Burkitt LymphomaPreclinical
United States
Welt Bio-Molecular Pharmaceutical
22 Mar 2024
Burkitt LymphomaPreclinical
United States
Biogent Consultants, LLC
22 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free